levocetirizine dihydrochloride
NDC 50228-136, levocetirizine dihydrochloride, tablet, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-136
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203646
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-136-10 | 50228013610 | 1000 TABLET in 1 BOTTLE (50228-136-10) |
| 50228-136-30 | 50228013630 | 30 TABLET in 1 BOTTLE (50228-136-30) |
| 50228-136-90 | 50228013690 | 90 TABLET in 1 BOTTLE (50228-136-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bd7fe481-dfe7-4dfd-aa05-6e2318a9234eNADAC price for package 50228013630
GET /v1/drugs/nadac/50228013630NADAC price for package 50228013690
GET /v1/drugs/nadac/50228013690
Use it
Look up 50228-136 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-136. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.